focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Tue, 21st Apr 2020 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

LIBERUM RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 5100 (4700) PENCE

----------

UBS RAISES RBS TO 'BUY' ('NEUTRAL') - PRICE TARGET 150 (215) PENCE

----------

GOLDMAN SACHS CUTS BHP GROUP PRICE TARGET TO 1680 (1700) PENCE - 'BUY'

----------

RBC CUTS LAND SECURITIES PRICE TARGET TO 825 (1100) PENCE - 'OUTPERFORM'

----------

RBC CUTS BRITISH LAND PRICE TARGET TO 455 (575) PENCE - 'SECTOR PERFORM'

----------

KEPLER CHEUVREUX RAISES ASTRAZENECA PRICE TARGET TO 8300 (7700) PENCE - 'BUY'

----------

JPMORGAN CUTS ST JAMES'S PLACE PRICE TARGET TO 937 (1325) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS PRUDENTIAL PRICE TARGET TO 1031 (1425) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PHOENIX GROUP PRICE TARGET TO 786 (904) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS LEGAL & GENERAL PRICE TARGET TO 200 (284) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS AVIVA PRICE TARGET TO 332 (498) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BP PRICE TARGET TO 425 (475) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROYAL DUTCH SHELL A PRICE TARGET TO 1650 (1750) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SHELL B PRICE TARGET TO 1650 (1750) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS TAYLOR WIMPEY PRICE TARGET TO 186 (206) PENCE - 'BUY'

----------

JEFFERIES CUTS PERSIMMON PRICE TARGET TO 3245 (3531) PENCE - 'BUY'

----------

JEFFERIES CUTS BERKELEY GROUP PRICE TARGET TO 5727 (5779) PENCE - 'BUY'

----------

JEFFERIES CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 659 (729) PENCE - 'BUY'

----------

GOLDMAN CUTS PEARSON PRICE TARGET TO 625.2 (658) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

GOLDMAN CUTS CAPITA TO 'BUY' ('CONVICTION BUY LIST') - TARGET 70 (200) PENCE

----------

BANK OF AMERICA INITIATES INVESTEC WITH 'BUY' - PRICE TARGET 190 PENCE

----------

LIBERUM CUTS BIG YELLOW GROUP PRICE TARGET TO 1000 (1100) PENCE - 'HOLD'

----------

RBC CUTS GREAT PORTLAND PRICE TARGET TO 550 (600) PENCE - 'UNDERPERFORM'

----------

RBC CUTS DERWENT LONDON PRICE TARGET TO 2750 (2900) PENCE - 'UNDERPERFORM'

----------

JPMORGAN CUTS JUST GROUP PRICE TARGET TO 59 (79) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS MITCHELLS & BUTLERS PRICE TARGET TO 400 (530) PENCE - 'BUY'

----------

JEFFERIES CUTS MARSTONS PRICE TARGET TO 35 (90) PENCE - 'UNDERPERFORM'

----------

JEFFERIES RAISES JD WETHERSPOON TO 'BUY' ('HOLD') - TARGET 1150 (1590) PENCE

----------

JEFFERIES CUTS REDROW PRICE TARGET TO 697 (809) PENCE - 'BUY'

----------

JEFFERIES CUTS CREST NICHOLSON PRICE TARGET TO 331 (362) PENCE - 'BUY'

----------

JEFFERIES CUTS COUNTRYSIDE PROPERTIES PRICE TARGET TO 587 (606) PENCE - 'BUY'

----------

JEFFERIES CUTS BELLWAY PRICE TARGET TO 3942 (4180) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

INVESTEC CUTS PREMIER OIL TO 'HOLD' ('BUY') - TARGET 25 (135) PENCE

----------

SHORE CAPITAL RESUMES HOLLYWOOD BOWL WITH 'BUY'

----------

LIBERUM RESUMES JOULES WITH 'BUY'

----------

JEFFERIES CUTS RESTAURANT GROUP PRICE TARGET TO 80 (170) PENCE - 'BUY'

----------

KEPLER CHEUVREUX CUTS HUNTING PRICE TARGET TO 230 (240) PENCE - 'HOLD'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.